Jana Musilkova

Dr. Jana Musilkova


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Biotechnology Advances
Verified
Journal Article
Closed access
Lucie BacakovaLucie Bacakova
Lucie Bacakova
JZJana Zarubova
Jana Zarubova
MTMartina Travnickova
Martina Travnickova
JMJana Musilkova
Jana Musilkova
JPJulia Pajorova
Julia Pajorova
MMMartin Molitor
Martin Molitor

1 February 2016 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MZMarketa Zikmundova
Marketa Zikmundova
JMJana Musilkova
Jana Musilkova
TRTomáš Riedel
Tomáš Riedel
DSDenisa Stranska
Denisa Stranska
EBEduard Brynda
Eduard Brynda
MZMargit Zaloudkova
Margit Zaloudkova
Fibrin plays an important role during wound healing and skin regeneration. It is often applied in clinical practice for treatment of skin injuries or as a component of skin substitutes. We prepared electrospun nanofibrous membranes made from poly(L-lactide) modified with a thin fibrin nanocoating. Fibrin surrounded the individual fibers in the membrane and also formed a thin fibrous mesh on several places on the membrane surface. The cell-free fibrin nanocoating remained stable in the cell culture medium for 14 days and did not change its morphology. On membranes populated with human dermal fibroblasts, the rate of fibrin degradation correlated with the degree of cell proliferation. The cell spreading, mitochondrial activity, and cell population density were significantly higher on membranes coated with fibrin than on nonmodified membranes, and this cell performance was further improved by the addition of ascorbic acid in the cell culture medium. Similarly, fibrin stimulated the expression and synthesis of collagen I in human dermal fibroblasts, and this effect was further enhanced by ascorbic acid. The expression of beta1-integrins was also improved by fibrin, and on pure polylactide membranes, it was slightly enhanced by ascorbic acid. In addition, ascorbic acid promoted deposition of collagen I in the form of a fibrous extracellular matrix. Thus, the combination of nanofibrous membranes with a fibrin nanocoating and ascorbic acid seems to be particularly advantageous for skin tissue engineering.

10 October 2018
Verified
Book Chapter
Open access
PDF file
Lucie BacakovaLucie Bacakova
Lucie Bacakova
MTMartina Travnickova
Martina Travnickova
EFElena Filova
Elena Filova
Roman MatějkaRoman Matějka
Roman Matějka
JSJana Stepanovska
Jana Stepanovska
MMMartin Molitor
Martin Molitor
Vascular smooth muscle cells (VSMCs) play important roles not only in the physiological functions of the blood vessels, such as vasoconstriction, vasodilatation and extracellular matrix production, but also in the pathogenesis of vascular diseases, particularly atherosclerosis and hypertension. VSMCs are mostly of mesodermal origin, although some are of neuroectodermal origin, for example, VSMCs present in the aorta and in blood vessels arising from the aortic arch. VSMCs of neuroectodermal origin are implicated in defects of cardiovascular morphogenesis, such as bicuspid aortic valve, coarctation of the aorta, patent ductus arteriosus and tetralogy of Fallot. The origin, location in the vascular tree, gender, species, strain and age influence the phenotype of VSMCs and their propensity to migration and growth. In a healthy adult organism, VSMCs have a quiescent and differentiated contractile phenotype characterized by early markers (e.g., SM α-actin, SM22-α), intermediate markers (h-caldesmon, calponin) and late markers (SM myosins, smoothelin) of VSMC differentiation. However, after blood vessel injury, surgery or explantation in vitro, VSMCs undergo a phenotypic modulation to synthetic phenotype, which endows them with high activity in migration, growth and proteosynthesis. These features can lead to stenosis or to obliteration of the vascular lumen and impaired blood supply to various tissues and organs.

1 December 2011 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
MSM. Soták
M. Soták
LPL. Polidarová
L. Polidarová
JMJana Musilkova
Jana Musilkova
MHM. Hock
M. Hock
ASA. Sumová
A. Sumová
JPJiri Pacha
Jiri Pacha
The intestinal transport of nutrients exhibits distinct diurnal rhythmicity, and the enterocytes harbor a circadian clock. However, temporal regulation of the genes involved in colonic ion transport, i.e., ion transporters and channels operating in absorption and secretion, remains poorly understood. To address this issue, we assessed the 24-h profiles of expression of genes encoding the sodium pump (subunits Atp1a1 and Atp1b1), channels (α-, β-, and γ-subunits of Enac and Cftr), transporters ( Dra, Ae1, Nkcc1, Kcc1, and Nhe3), and the Na+/H+ exchanger (NHE) regulatory factor ( Nherf1) in rat colonic mucosa. Furthermore, we investigated temporal changes in the spatial localization of the clock genes Per1, Per2, and Bmal1 and the genes encoding ion transporters and channels along the crypt axis. In rats fed ad libitum, the expression of Atp1a1, γ Enac, Dra, Ae1, Nhe3, and Nherf1 showed circadian variation with maximal expression at circadian time 12, i.e., at the beginning of the subjective night. The peak γ Enac expression coincided with the rise in plasma aldosterone. Restricted feeding phase advanced the expression of Dra, Ae1, Nherf, and γ Enac and decreased expression of Atp1a1. The genes Atp1b1, Cftr, α Enac, β Enac, Nkcc1, and Kcc1 did not show any diurnal variations in mRNA levels. A low-salt diet upregulated the expression of β Enac and γ Enac during the subjective night but did not affect expression of α Enac. Similarly, colonic electrogenic Na+ transport was much higher during the subjective night than the subjective day. These findings indicate that the transporters and channels operating in NaCl absorption undergo diurnal regulation and suggest a role of an intestinal clock in the coordination of colonic NaCl absorption.

1 November 1990 in Molecular Pharmacology
Verified
Journal Article
Closed access
STS Tucek
S Tucek
JMJana Musilkova
Jana Musilkova
JNJ Nedoma
J Nedoma
JPJ Proska
J Proska
SSS Shelkovnikov
S Shelkovnikov
JVJ Vorlícek
J Vorlícek

1 September 2001 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
JMJana Musilkova
Jana Musilkova
JKJan Kovář
Jan Kovář